CYP 2.13% 24.0¢ cynata therapeutics limited

Ann: Cynata Receives $1.39m R&D Tax Incentive Refund, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 859 Posts.
    lightbulb Created with Sketch. 342
    No he didn't. More capital will be needed, however it is TBC whether that will come via a CR or through revenue from a (hopefully more than 1) commercial license agreement. This is over 2 years away - no point worrying about that now. Data from the clinical trials we're running will be in by then and the market (and potential commercial partners/acquirers) will have a far better idea of what Cynata and the Cymerus manufacturing process is worth.
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.